In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-02-01
DOI
https://doi.org/10.7326/annals-24-03608-jc
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y

James D. Douketis, Eleni Korompoki
Annals of Internal Medicine
Cerebrovascular and Carotid Artery Diseases
article

In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y

James D. Douketis, Eleni Korompoki
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(2)
National and Kapodistrian University of Athens (GR), McMaster University (CA)
Good health and well-being
Openalex Percentile: Top 97%
Cerebrovascular and Carotid Artery Diseases
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y — James D. Douketis, Eleni Korompoki · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS